When a team like the Kansas City Chiefs has as much success as they have, winning can hide the obvious flaws that could determine whether they are the pitfalls to the lack of success when it ...

Malnutrition, I saw on this trip, is a vast and under-addressed problem — but also one that we can solve if we commit to it. Nicholas Kristof became a columnist for The Times Opinion desk in ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Nevro (NVRO) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

NYSE:NVRO opened at $5.72 on Monday. The stock has a market cap of $214.33 million, a PE ratio of -3.03 and a beta of 0.91. Nevro has a fifty-two week low of $3.16 and a fifty-two week high of $17 ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

In a report released on February 7, Nathan Treybeck from Wells Fargo maintained a Hold rating on Nevro Corp (NVRO – Research Report), with a price target of $5.85. The company’s shares closed ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Corp (NVRO – Research Report) and Ansell (ANSLF – Research Report). Nevro Corp (NVRO) RBC Capital ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...